Corporate ActionMay 28, 2026, 05:27 PM
Soligenix Increases At-Market Equity Offering by $2.96M
AI Summary
Soligenix, Inc. filed a prospectus supplement on May 28, 2026, to increase the maximum aggregate offering amount of its common stock under an At Market Issuance Sales Agreement with Rodman & Renshaw LLC. The company added an additional $2,956,000 to the offering, bringing the total potential amount to approximately $6,401,000, following previous sales of $3,445,000. This action allows Soligenix to potentially raise more capital through equity sales.
Key Highlights
- Soligenix increased its At Market Issuance Sales Agreement by an additional $2,956,000.
- The total potential offering amount under the agreement is now approximately $6,401,000.
- The company previously sold approximately $3,445,000 of common stock under the agreement.
- The sales agreement is with Rodman & Renshaw LLC, dated January 23, 2026.
- A prospectus supplement was filed on May 28, 2026, to effect this increase.
Price Impact
More from SNGX